Expression of two transgenes in in vitro matured and fertilized bovine zygotes after DNA microinjection.
Bovine zygotes produced by in vitro maturation-in vitro fertilization (IVM-IVF) were examined for their potential to serve as recipients of transgenes. Pronuclei, which were maximally visible at about 22 h after IVF, were injected with a SV40-LacZ construct (pSVON). Injected zygotes had lower cleavage rates (49.1%, n = 1162, P < 0.01) than did either noninjected controls (87.4%, n = 1420) or noninjected zygotes in which pronuclei were not visible (67.6%, n = 803). Zygotes that were injected into their pronuclei cleaved as well as zygotes injected cytoplasmically. At 48 h after injection, when most embryos had reached the four- and eight-cell stages, more zygotes in the pronuclear group (22.7%, n = 125) stained positively for LacZ than did zygotes in the cytoplasmic group (8.0%, n = 125). A group of zygotes injected into the pronucleus with pSVON was cultured for 9 days. More morulae (10.8%, n = 134) than blastocysts (3.2%, n = 31) expressed the LacZ gene, indicating that silencing of expression occurred as development progressed. Another group of zygotes was injected with a beta-actin-LacZ gene construct (pbActinLacZ) and, of the embryos assayed at 48 h, 10.6% (n = 255) stained positively. At 9 days, 36.3% of morulae (n = 91) and 21% of blastocysts (n = 33) expressed the transgene. Almost all putative transgenic embryos injected with either construct showed a mosaic pattern of LacZ expression, with an average of only 2-3 cells staining at the eight-cell stage and the majority of cells in positive blastocysts showing no evidence of expression.
Kubisch
H M
HM
Department of Animal Sciences, University of Missouri-Columbia 65211, USA.
Hernandez-Ledezma
J J
JJ
Larson
M A
MA
Sikes
J D
JD
Roberts
R M
RM
D000818:Animals; D030801:Animals, Genetically Modified; D002417:Cattle / Q000235:genetics*; D003593:Cytoplasm; D004247:DNA; D005260:Female; D005307:Fertilization in Vitro; D015870:Gene Expression; D018014:Gene Transfer Techniques; D008845:Microinjections; D013539:Simian virus 40; D015053:Zygote
D004247:DNA